Abstract
Dear Editor,
We read with great interest the paper by Gupta et al 1 comparing the Revised Risk Analysis Index (RAI-Rev) and the 5-Factor Modified Frailty Index (mFI-5) for predicting outcomes in Degenerative Cervical Myelopathy (DCM), a commendable large-scale analysis contributing to the ongoing effort to refine frailty-based risk stratification in spine surgery. However, several aspects may merit further consideration.
The study’s reliance on the ACS-NSQIP database inevitably restricts the granularity of the frailty assessment. Critical components of frailty such as cognitive impairment, sarcopenia, nutritional status, and preoperative functional scores were not available.2,3 Integrating measures such as preoperative gait analysis, grip strength, or even patient-reported outcomes could yield a more holistic understanding of frailty’s impact.
While the study stratifies outcomes by anterior vs posterior approach, the reasons behind surgical selection remain unexamined. NSQIP lacks detailed radiographic or anatomical data (eg, sagittal alignment, multilevel disease burden, ossification of the posterior longitudinal ligament) guiding approach selection. It is difficult to decide whether the observed differences in frailty’s predictive value between anterior and posterior approaches reflect true biologic interaction or underlying selection bias.
The finding that frailty had greater predictive accuracy in anterior approaches compared to posterior ones raises intriguing clinical questions. 4 Does this suggest that posterior decompression is inherently more frailty-tolerant, or rather that anterior approaches magnify frailty-related risks due to dysphagia and pulmonary complications? The authors briefly touch upon dysphagia, but it would be compelling to see an analysis of approach-specific complications stratified by frailty tier. For instance, whether the incidence of postoperative dysphagia in frail anterior patients disproportionately drives non-home discharge rates.
The relatively low overall mortality (0.4%) may obscure frailty’s true impact on survival in higher-risk subgroups. 5 As the authors note, very frail patients (RAI-Rev ≥41) were underrepresented in the NSQIP dataset, limiting conclusions. Targeted prospective cohorts of the very frail could clarify whether posterior approaches truly mitigate mortality risk or simply redistribute morbidity.
While the study appropriately emphasizes statistical discrimination, clinical translation requires consideration of calibration and net benefit. A frailty index with modestly higher discrimination may still fail to meaningfully alter patient or surgeon decisions unless it improves absolute risk estimation. Decision-curve analysis or incorporation into risk calculators could help demonstrate how RAI-Rev changes perioperative management compared to the simpler mFI-5.
If RAI-Rev more accurately identifies high-risk patients, care should evolve accordingly. A protocolized pathway for high-RAI individuals could include prehabilitation (targeted nutrition and protein supplementation, resistance training, correction of anemia and polypharmacy), tailored ERAS modifications, and early discharge planning with social work support. To validate this care pathway, a stepped-wedge or pragmatic randomized trial could assess its clinical utility and cost-effectiveness in routine practice.
In summary, Gupta et al show RAI-Rev outperforms mFI-5 in DCM, especially for non-fatal outcomes, reinforcing the importance of frailty in surgical decisions. Future studies should move beyond database constraints to assess real-world applicability across cognitive, functional, and imaging factors. We look forward to further refinements of frailty-based risk refinement in spine surgery.
